BGACF OTC
BioNeutra Global Corporation
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: +0.0%
$0.01
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$11M
-15.0% ▼
5Y CAGR: -21.3%
Gross Profit
$4M
+76.4% ▲
5Y CAGR: -16.8%
Operating Income
-$1M
+40.5% ▲
Net Income
-$2M
+27.8% ▲
EPS (Diluted)
$-0.05
+27.8% ▲
EBITDA
-$352K
+74.1% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|---|
| Revenue | $38M | $24M | $15M | $13M | $11M |
| YoY Growth | -0.0% | -36.0% | -36.1% | -13.1% | -15.0% |
| Cost of Revenue | $37M | $20M | $13M | $11M | $7M |
| Gross Profit | $638K | $4M | $3M | $2M | $4M |
| Gross Margin | 1.7% | 16.4% | 18.8% | 17.5% | 36.4% |
| R&D Expenses | $440K | $257K | $12K | -$16K | $146K |
| SG&A Expenses | $9M | $4M | $4M | $4M | $4M |
| Operating Expenses | $9M | $7M | $5M | $5M | $6M |
| Operating Income | -$10M | -$3M | -$2M | -$2M | -$1M |
| Operating Margin | -26.1% | -12.5% | -15.3% | -18.1% | -12.6% |
| Interest Expense | $596K | $433K | $391K | $450K | $697K |
| Income Before Tax | -$13M | -$4M | -$3M | -$3M | -$2M |
| Tax Expense | -$577K | -$65K | $0 | $0 | $0 |
| Net Income | -$12M | -$4M | -$3M | -$3M | -$2M |
| Net Margin | -33.0% | -15.4% | -18.4% | -21.8% | -18.5% |
| EPS (Diluted) | $-0.27 | $-0.08 | $-0.06 | $-0.06 | $-0.05 |
| EBITDA | -$10M | -$1M | -$1M | -$1M | -$352K |
| Shares Outstanding | 46M | 46M | 46M | 46M | 46M |